Codiak BioSciences, Inc. Accrued Liabilities, Current
Codiak BioSciences, Inc. had Accrued Liabilities, Current of $8.13 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-11-03
- 2022-09-30: Accrued Liabilities, Current $8.13M.
- 2022-06-30: Accrued Liabilities, Current $7.70M.
- 2022-03-31: Accrued Liabilities, Current $6.81M.
- 2021-12-31: Accrued Liabilities, Current $9.70M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2022-09-30 | $8.13M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $7.70M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $6.81M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $9.70M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $9.31M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $7.69M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.80M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.87M 10-K · filed 2022-03-10 |
| 2020-09-30 | $23.86M 10-Q · filed 2020-11-19 |
| 2019-12-31 | $15.82M 10-K · filed 2021-03-17 |